VBI Vaccines Inc. (NASDAQ:VBIV) does about 803.79K shares in volume on a normal day but saw 7528272 shares change hands in the recent trading day. The company now has a market cap of 2.70M USD. Its current market price is $0.09, marking a decrease of -18.97% compared to the previous close of $0.12. The 52 week high reached by this stock is $1.35 whilst the lowest price level in 52 weeks is $0.11.
VBI Vaccines Inc. (VBIV) has a 20-day trading average at $0.5600 and the current price is -93.04% off the 52-week high compared with -15.85% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.6001 and its 200-day simple moving average is $0.6102. If we look at the stock’s price movements over the week, volatility stands at 43.58%, which decreases to 18.98% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 14.62 to suggest the stock is oversold.
The consensus objective for the share price is $5.00, suggesting that the stock has a potential upside of 98.2% over the period.
0 analysts have rated it as a buy and 1 have advised that investors hold their positions. The consensus recommendation rating is Strong Buy and Wall Street’s advice is for investors to Moderate Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 11, 2022 when Raymond James downgraded the stock to “Outperform” and issued a price target of between $5 and $2. Jefferies initiated its price target at $7.
VBI Vaccines Inc. (VBIV) stock is down -83.21% over the week and -87.46% over the past month. Its price is -84.00% year-to-date and -92.66% over the past year.
To reach the target analysts have set, the stock logically needs to grow 98.2 percent from here.
The company has a return on equity of -419.59%. The beta has a value of 2.16. Price to sales ratio is 0.29.
